256 Newsroom — Uganda's Digital News Infrastructure
Business

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Capricor Therapeutics, Inc.

Published by Capricor.com 13 August 2026 at 23:07
Share
Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Capricor Therapeutics, Inc.
Image · Capricor.com

What the report says

Deramiocel Biologics License Application (BLA) under active FDA review HOPE-3 Phase 3 results published in The Lancet; primary endpoint of upper…...

Read the full report at Capricor.com →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

OPINION: My Child Is Back at School, but My Bank Account Is Still on HolidayNile Post 256 Newsroom URA Lauds Manufacturers on Digital Tax Stamps Success - chimpreports.comChimpReports How Northern Uganda’s Artists Are Taking Local Sounds Beyond KampalaNile Post URA lauds Manufacturers on DTS successNile Post COSASE piles pressure on BoU over Shs140 billion Habba guaranteeThe Independent Uganda Housing Finance Bank deepens Hoima presence as Bunyoro economy expandsThe Independent Uganda